Literature DB >> 11070013

Epstein-Barr virus that lacks glycoprotein gN is impaired in assembly and infection.

C M Lake1, L M Hutt-Fletcher.   

Abstract

The Epstein-Barr virus (EBV) glycoproteins N and M (gN and gM) are encoded by the BLRF1 and BBRF3 genes. To examine the function of the EBV gN-gM complex, recombinant virus was constructed in which the BLRF1 gene was interrupted with a neomycin resistance cassette. Recombinant virus lacked not only gN but also detectable gM. A significant proportion of the recombinant virus capsids remained associated with condensed chromatin in the nucleus of virus-producing cells, and cytoplasmic vesicles containing enveloped virus were scarce. Virus egress was impaired, and sedimentation analysis revealed that the majority of the virus that was released lacked a complete envelope. The small amount of virus that could bind to cells was also impaired in infectivity at a step following fusion. These data are consistent with the hypothesis that the predicted 78-amino-acid cytoplasmic tail of gM, which is highly charged and rich in prolines, interacts with the virion tegument. It is proposed that this interaction is important both for association of capsids with cell membrane to assemble and release enveloped particles and for dissociation of the capsid from the membrane of the newly infected cell on its way to the cell nucleus. The phenotype of EBV lacking the gN-gM complex is more striking than that of most alphaherpesviruses lacking the same complex but resembles in many respects the phenotype of pseudorabies virus lacking glycoproteins gM, gE, and gI. Since EBV does not encode homologs for gE and gI, this suggests that functions that may have some redundancy in alphaherpesviruses have been concentrated in fewer proteins in EBV.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11070013      PMCID: PMC113204          DOI: 10.1128/jvi.74.23.11162-11172.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Purification of herpes simplex virus type 1 by density gradient centrifugation and estimation of the sedimentation coefficient of the virion.

Authors:  B Sathananthan; E Rødahl; T Flatmark; N Langeland; L Haarr
Journal:  APMIS       Date:  1997-03       Impact factor: 3.205

2.  CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA).

Authors:  J V PULVERTAFT
Journal:  Lancet       Date:  1964-02-01       Impact factor: 79.321

3.  The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells.

Authors:  Q Li; S M Turk; L M Hutt-Fletcher
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

4.  The Epstein-Barr virus glycoprotein 110 carboxy-terminal tail domain is essential for lytic virus replication.

Authors:  S K Lee; R Longnecker
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

5.  Synthesis and processing of the equine herpesvirus 1 glycoprotein M.

Authors:  N Osterrieder; A Neubauer; B Fakler; C Brandmüller; C Seyboldt; O R Kaaden; J D Baines
Journal:  Virology       Date:  1997-05-26       Impact factor: 3.616

6.  Bovine herpesvirus 1 UL49.5 homolog gene encodes a novel viral envelope protein that forms a disulfide-linked complex with a second virion structural protein.

Authors:  X Liang; B Chow; C Raggo; L A Babiuk
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

7.  Identification and characterization of pseudorabies virus glycoprotein gM as a nonessential virion component.

Authors:  J M Dijkstra; N Visser; T C Mettenleiter; B G Klupp
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

8.  Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes.

Authors:  Q Li; M K Spriggs; S Kovats; S M Turk; M R Comeau; B Nepom; L M Hutt-Fletcher
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

9.  Disruption of the varicella-zoster virus dUTPase and the adjacent ORF9A gene results in impaired growth and reduced syncytia formation in vitro.

Authors:  J Ross; M Williams; J I Cohen
Journal:  Virology       Date:  1997-08-04       Impact factor: 3.616

10.  The equine herpesvirus 1 glycoprotein gp21/22a, the herpes simplex virus type 1 gM homolog, is involved in virus penetration and cell-to-cell spread of virions.

Authors:  N Osterrieder; A Neubauer; C Brandmuller; B Braun; O R Kaaden; J D Baines
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more
  28 in total

1.  Analysis of the requirement for glycoprotein m in herpes simplex virus type 1 morphogenesis.

Authors:  Helena Browne; Susanne Bell; Tony Minson
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

2.  Epstein-Barr virus shed in saliva is high in B-cell-tropic glycoprotein gp42.

Authors:  R Jiang; R S Scott; L M Hutt-Fletcher
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  Glycoprotein M of herpes simplex virus 1 is incorporated into virions during budding at the inner nuclear membrane.

Authors:  Joel D Baines; Elizabeth Wills; Robert J Jacob; Janice Pennington; Bernard Roizman
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

4.  The carboxy-terminal domain of glycoprotein N of human cytomegalovirus is required for virion morphogenesis.

Authors:  Michael Mach; Karolina Osinski; Barbara Kropff; Ursula Schloetzer-Schrehardt; Magdalena Krzyzaniak; William Britt
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

Review 5.  Epstein-Barr virus entry.

Authors:  Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

6.  Envelope glycoprotein gB of Kaposi's sarcoma-associated herpesvirus is essential for egress from infected cells.

Authors:  Harinivas H Krishnan; Neelam Sharma-Walia; Ling Zeng; Shou-Jiang Gao; Bala Chandran
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Kaposi's sarcoma-associated herpesvirus glycoproteins B and K8.1 regulate virion egress and synthesis of vascular endothelial growth factor and viral interleukin-6 in BCBL-1 cells.

Authors:  R Subramanian; I Sehgal; O D'Auvergne; K G Kousoulas
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

8.  HCMV-encoded glycoprotein M (UL100) interacts with Rab11 effector protein FIP4.

Authors:  Magdalena A Krzyzaniak; Michael Mach; William J Britt
Journal:  Traffic       Date:  2009-10       Impact factor: 6.215

9.  Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus.

Authors:  Ieva Bagdonaite; Rickard Nordén; Hiren J Joshi; Sarah L King; Sergey Y Vakhrushev; Sigvard Olofsson; Hans H Wandall
Journal:  J Biol Chem       Date:  2016-04-15       Impact factor: 5.157

10.  Detection of EBV infection and gene expression in oral cancer from patients in Taiwan by microarray analysis.

Authors:  Ching-Yu Yen; Min-Chi Lu; Ching-Cherng Tzeng; Jia-Yan Huang; Hsueh-Wei Chang; Ruey-Shyang Chen; Shyun-Yeu Liu; Shih-Tung Liu; Biehuoy Shieh; Ching Li
Journal:  J Biomed Biotechnol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.